Lexaria Bioscience Corp (NASDAQ: LEXX) Share Price, LEXX Stock News, LEXX Share Price & Updates

Lexaria Celebrates its 70th Patent Award

Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule

Lexaria Bioscience Completes Enrollment And Continues Dosing On Schedule In Two Oral Semaglutide Pilot Study Comparing DehydraTECH Formulations To Wegovy Tablets

Lexaria tests its first oral tablet formula against Wegovy

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Lexaria Announces Results from Animal Study GLP-1-A26-1

Lexaria Bioscience Announces Results From Animal Study GLP-1-A26-1 Evaluating Both DehydraTECH-CBD Compositions And DehydraTECH-Semaglutide; Unfortunately, The DHT-SEMA Concentrations In Brain Tissue Were All At Levels Below The Lower Limit Of Quantitation Of The Bioassay Utilized In This Study

A CBD formula showed 566% more brain absorption in rats 8 hours after dosing.

12 Health Care Stocks Moving In Wednesday's After-Market Session

GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications

Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

LEXX: Introducing DehydraTECH 3.0

Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference